Mandate

Vinge has advised Pareto Securities AB and Nordea Bank AB (publ) in connection with a bond issue of up to 150 MEUR

April 18, 2017 Banking and Finance

Vinge has advised Pareto Securities AB and Nordea Bank AB (publ) in connection with a bond issue of up to 150 MEUR, issued by Cembrit Group A/S on 20 March 2017.

Pareto Securities AB and Nordea Bank AB (publ) acted as joint bookrunners. The bonds have a tenor of four years and a floating interest rate of three-months Euribor plus a floating rate margin of 5.50 per cent.

The proceeds from the bond issue will be issued to refinance existing debt and for general corporate purposes. Cembrit Group A/S will apply for the bonds to be listed on Nasdaq Stockholm.

Vinges team consisted of Mikael Ståhl, André Isacson and Lionardo Ojeda.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026